The Hematopoietic Cell Transplant Pharmacist: A Call to Action

Recently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bo...

Full description

Bibliographic Details
Main Author: Amber Clemmons
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/8/1/3
id doaj-8b2645c6130f47a092ed1c624b90922c
record_format Article
spelling doaj-8b2645c6130f47a092ed1c624b90922c2020-11-25T02:20:43ZengMDPI AGPharmacy2226-47872020-01-0181310.3390/pharmacy8010003pharmacy8010003The Hematopoietic Cell Transplant Pharmacist: A Call to ActionAmber Clemmons0College of Pharmacy, Department of Clinical and Administrative Pharmacy, University of Georgia, Augusta, GA 30912, USARecently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bone Marrow Transplantation. While these documents establish the roles a HCT pharmacist can fulfill within the multi-disciplinary team, few reports have evaluated the impact of the HCT pharmacist on clinical, financial, or quality outcomes. Further, a paucity of information has been reported on types of practice models, such as the use of collaborative practice agreements, or described effective methods to overcome the barriers to the increased utilization of HCT pharmacists. Herein, a brief summary of available information is provided to aid readers in understanding the state of the science for pharmacists practicing in this specialty with the goal to stimulate further research to justify the roles of HCT pharmacists and the correlation of such research to various outcome measures. Practitioners are encouraged to build upon this existing knowledge to create the novel integration and elevation of pharmacy practice to improve outcomes for patients, providers, and payors.https://www.mdpi.com/2226-4787/8/1/3bone marrowclinical pharmacy servicehematopoieticresponsibilitiesrolestransplantation
collection DOAJ
language English
format Article
sources DOAJ
author Amber Clemmons
spellingShingle Amber Clemmons
The Hematopoietic Cell Transplant Pharmacist: A Call to Action
Pharmacy
bone marrow
clinical pharmacy service
hematopoietic
responsibilities
roles
transplantation
author_facet Amber Clemmons
author_sort Amber Clemmons
title The Hematopoietic Cell Transplant Pharmacist: A Call to Action
title_short The Hematopoietic Cell Transplant Pharmacist: A Call to Action
title_full The Hematopoietic Cell Transplant Pharmacist: A Call to Action
title_fullStr The Hematopoietic Cell Transplant Pharmacist: A Call to Action
title_full_unstemmed The Hematopoietic Cell Transplant Pharmacist: A Call to Action
title_sort hematopoietic cell transplant pharmacist: a call to action
publisher MDPI AG
series Pharmacy
issn 2226-4787
publishDate 2020-01-01
description Recently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bone Marrow Transplantation. While these documents establish the roles a HCT pharmacist can fulfill within the multi-disciplinary team, few reports have evaluated the impact of the HCT pharmacist on clinical, financial, or quality outcomes. Further, a paucity of information has been reported on types of practice models, such as the use of collaborative practice agreements, or described effective methods to overcome the barriers to the increased utilization of HCT pharmacists. Herein, a brief summary of available information is provided to aid readers in understanding the state of the science for pharmacists practicing in this specialty with the goal to stimulate further research to justify the roles of HCT pharmacists and the correlation of such research to various outcome measures. Practitioners are encouraged to build upon this existing knowledge to create the novel integration and elevation of pharmacy practice to improve outcomes for patients, providers, and payors.
topic bone marrow
clinical pharmacy service
hematopoietic
responsibilities
roles
transplantation
url https://www.mdpi.com/2226-4787/8/1/3
work_keys_str_mv AT amberclemmons thehematopoieticcelltransplantpharmacistacalltoaction
AT amberclemmons hematopoieticcelltransplantpharmacistacalltoaction
_version_ 1724870324359528448